Get started
Author

David Chun Cheong Tsui

Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
2012 · Jing Wang, Denis Gallagher, et al. · Cell stem cell · 482
PDF
FoxP2 Regulates Neurogenesis during Embryonic Cortical Development
2013 · David Tsui, John P. Vessey, et al. · Journal of Neuroscience · 153
PDF
CBP regulates the differentiation of interneurons from ventral forebrain neural precursors during murine development
2013 · David Tsui, Anastassia Voronova, et al. · Developmental Biology · 32
PDF
Serotonin mediates a learned increase in attraction to high concentrations of benzaldehyde in aged C. elegans
2008 · David Tsui, Derek van der Kooy · Learning & Memory · 27
PDF
Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib
2021 · David Chun Cheong Tsui, Brian D. Kavanagh, et al. · Clinical Lung Cancer · 20
Point of Care Liquid Biopsy for Cancer Treatment—Early Experience from a Community Center
2024 · Champica Nicholas, Andrea Beharry, et al. · Cancers · 14
1650P Adoption and early clinical outcomes of atezolizumab (atezo) + carboplatin and etoposide (CE) in patients with extensive-stage small cell lung cancer (ES-SCLC) in the real-world (RW) setting
2021 · D.C.C. Tsui, L. Polito, et al. · Annals of Oncology · 7
PDF
Genomic analysis of comprehensive next generation sequencing data to explore the criteria for MET amplification as an actionable biomarker in NSCLC
2025 · David Chun Cheong Tsui, Jessica K. Lee, et al. · Lung Cancer · 6
PDF
The Role of Local Therapy for Oligo-Progressive Disease in Oncogene-Addicted Non-Small-Cell Lung Cancer
2024 · David Chun Cheong Tsui, Douglas E. Holt, et al. · Advances in Radiation Oncology · 6
PDF
Association of anticoagulant use with clinical outcomes from crizotinib in ALK ‐ and ROS1‐rearranged advanced non‐small cell lung cancers: A retrospective analysis of PROFILE 1001
2022 · Terry L. Ng, David C. C. Tsui, et al. · Cancer Medicine · 6
PDF
Tumor Shrinkage With Combination of Alectinib and Trastuzumab in a Patient With ALK-Rearranged Non–small Cell Lung Cancer Harboring HER2-Amplification as an Acquired Resistance Mechanism to ALK Inhibitor Therapy
2021 · David Chun Cheong Tsui, Dara Aisner, et al. · Clinical Lung Cancer · 6
Oncogene Overlap Analysis of Circulating Cell-free Tumor DNA to Explore the Appropriate Criteria for Defining MET Copy Number–Driven Lung Cancer
2022 · David C.C. Tsui, Leylah M. Drusbosky, et al. · Clinical Lung Cancer · 5
PDF
Molecular Profiling of the Cerebrospinal Fluid in Leptomeningeal NSCLC: The Shape of Things to Come?
2021 · David Chun Cheong Tsui, D. Ross Camidge · Journal of Thoracic Oncology · 5
Effect of continuing osimertinib with chemotherapy in the post-progression setting on progression-free survival among patients with metastatic epidermal growth factor receptor (EGFR) positive non-small cell lung cancer.
2021 · Tejas Patil, David Chun Cheong Tsui, et al. · Journal of Clinical Oncology · 4
Real-world (rw) analysis of quantitative MET copy number (CN) as a biomarker in NSCLC.
2022 · David Chun Cheong Tsui, Jessica Kim Lee, et al. · Journal of Clinical Oncology · 3
Implementing standardized documentation for goals of care among advanced stage cancer patients.
2025 · Maddy Toker, William Raskin, et al. · Journal of Clinical Oncology · 1
PDF
P2.17-28 Real-World Data: Survival Outcomes of Chemotherapy Regimens Given Concurrently with Radiotherapy for Locally Advanced NSCLC
2018 · D.C.C. Tsui, C. Butts, et al. · Journal of Thoracic Oncology
Circulating Tumor DNA for Noninvasive Monitoring of Non-Small Cell Lung Cancer Patients Receiving EGFR-Targeted Therapies
2015 · Tsui, D, Muhammed, M, et al. · UCL Discovery (University College London)
Molecular Mechanisms Regulating Mammalian Forebrain Development
2014 · David Chun Cheong Tsui · TSpace (University of Toronto)
PDF
Works count: 19
Citation count: 777
H-index: 7
I10-index: 6
Year
Topic
Type